Stem cell therapy for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a new stem cell treatment (DT2-SCT) for people with type 2 diabetes who need insulin. It aims to see if the treatment is safe and helps control blood sugar better than a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 75 years old
- You have type 2 diabetes and use insulin (up to a certain daily amount)
- Your body mass index (BMI) is between 19 and 30
- Your fasting blood sugar is 7.0 mmol/L or higher, and your HbA1c is 7% or more
- You do not have a positive GAD antibody test (which is more common in type 1 diabetes)
- You are generally healthy, not pregnant, and willing to follow the study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
This trial tests whether a type of stem cell treatment (called cfMSC) can help people with long-standing type 2 diabetes who are not getting good blood sugar control from their current treatments. The therapy aims to improve blood sugar levels and may help preserve the body's ability to produce insulin.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
This trial tests whether injecting your own stem cells into the duodenum (the first part of the small intestine) is safe and possible for people with type 2 diabetes and insulin resistance. The goal is to see if this can help improve blood sugar control.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.